SLG
DXCM icon

Stanley-Laman Group’s DexCom DXCM Stock Holding History

Stanley-Laman Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-66,092
Closed -$6.11M – 246
2020
Q4 		$6.11M Buy
66,092
+4,256
+7% +$380K 1.08% 30
2020
Q3 		$6.37M Buy
61,836
+1,932
+3% +$202K 1.41% 18
2020
Q2 		$6.07M Buy
+59,904
New +$5.36M 1.46% 16
2019
Q3 		– Sell
-8,692
Closed -$326K – 269
2019
Q2 		$326K Buy
+8,692
New +$273K 0.08% 220

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Stanley-Laman Group's DXCM Position: Q1 2021 in Review

Stanley-Laman Group sold out of DexCom (DXCM) in Q1 2021, closing a stake of 66,092 shares — an estimated $6.11M sold.

Stanley-Laman Group first reported a position in DXCM in Q2 2019 and held it in 4 quarters. The position peaked at $6.37M in Q3 2020. 729 funds tracked by Wall St. Rank hold DXCM as of Q1 2021.

  • Stanley-Laman Group reported no remaining DexCom position as of Q1 2021 after selling out during the quarter.
  • Stanley-Laman Group sold 66,092 DexCom shares in Q1 2021, an estimated $6.11M.
  • Stanley-Laman Group first reported a position in DexCom in Q2 2019 and held it in 4 quarters.
  • Stanley-Laman Group's DexCom position peaked at $6.37M in Q3 2020.
  • 729 funds tracked by Wall St. Rank held DexCom as of Q1 2021.

Based on Stanley-Laman Group's 13F filing for Q1 2021, filed 5 May 2021.